Project CBD

FEBRUARY 27, 2023

In the absence of an answer — or a cure — treatment is the name of the game for fibromyalgia. “Available data strongly support the use of cannabinoids in treating fibromyalgia pain” due to “overwhelmingly positive treatment results.” That seemed to make all the difference. © Copyright, Project CBD.

THC 144

THC CBD Clinical Trials Sleep 144

Cannabis Law Report

AUGUST 3, 2021

Many mental health disorders have treatment options, but they aren’t nearly as safe and efficacious as conventional pharmaceuticals or therapies. CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. (CSE:

Research and Development 105

Research and Development Data Conditions Therapy 105

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Peer-reviewed analysis.

Cannabinoids 45

Cannabinoids Data Chronic Pain Sleep 45

The Cannigma

FEBRUARY 2, 2021

In light of these results, the researchers behind the survey say that physicians should pay special consideration to these aspects when advising patients on their medical cannabis treatment options. Physicians should consider these aspects when advising their patients about treatment with medicinal cannabis.

Patients 105

Patients Clinical Trials Research and Development Treatment 105

Cannabis Law Report

JUNE 30, 2021

In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials. Even if there’s an accurate diagnosis, many mental health treatments have less-than-desirable efficacy, and there can be significant side effects.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 40

Epilepsy Pharmaceutical Data Clinical Trials 40

The Joint Blog

MARCH 27, 2019

” Acute treatment with CBD (at doses of 0.3 “The antinociceptive effect of CBD (3 mg/Kg) was not altered by the pre-treatment with CB 1 or CB 2 receptor antagonists (AM251 and AM630; respectively; both at a dose of 1 mg/kg, i.p.) ” Acute treatment with CBD (at doses of 0.3 Sub-chronic treatment with CBD (0.3

Treatment 48

Treatment CBD Data Conditions 48

CannaMD

NOVEMBER 4, 2020

Read on to learn how medical marijuana helps migraines and headaches, and why neurologists are increasingly optimistic about this non-traditional treatment! The present study relied on Migraine Buddy , a leading mobile application that tracks migraine symptoms. Marijuana & Migraine Studies. The results? 28 million are women.

Patients 105

Patients Chronic Pain Marijuana Research and Development 105

Cannabis Law Report

AUGUST 27, 2021

The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future. Chris Ray , PhD : Interventional Pain Physician. About Delic Corp, Inc.

Research and Development 98

Research and Development Treatment Media Medicine 98

Veriheal

NOVEMBER 21, 2023

Quemarr presents an emulsion-based drug delivery system tailored for cannabinoids and made to tackle America’s diabetes crisis. Quemarr’s transformative approach to diabetes treatment offers patients a less intrusive alternative to conventional insulin treatments.

Research and Development 110

Research and Development Consumption Education Data 110

LifeCannMD

MAY 27, 2025

Now, with 1.5mg of a balanced THC:CBD tincture twice daily, he’s giving presentations at work and actually enjoying social events again. Sleep: What the Sleep Studies Reveal A groundbreaking 2020 study from the University of New Mexico analyzed sleep data from over 5,000 medical marijuana patients.

Microdosing 52

Microdosing Research and Development Sleep Chronic Pain 52

Veriheal

JANUARY 4, 2021

In adults with chronic pain , what are the harms of Kratom or other plant-based substances for treatment of chronic pain? In adults with chronic pain, what are the benefits of Kratom or other plant-based substances for treatment of chronic pain? In adults with chronic pain, what are the harms of cannabinoids? A Statement from the AHRQ.

Chronic Pain 105

Chronic Pain Therapy Cannabinoids Treatment 105

Veriheal

MAY 16, 2022

Researchers working at the University of Arizona College of Medicine in Tucson have refined a method of ketamine use in the treatment of Parkinson’s disease (PD). Specifically, the group focused on ketamine’s ability to relieve the side effects of a common treatment called Levodopa. and Torsten Falk, Ph.D.,

Research and Development 19

Research and Development Treatment Clinical Trials Patients 19

Cannabis Law Report

JUNE 2, 2021

The latest article in Healthcare Business Today cites the company’s Multiomics Advanced Technology™ (MAT) as the driver for more accurate predictions about disease states and individual responses to diseases and treatments that will make medicine truly personalized. www.GATCHealth.com. Disclaimer.

Medicine 69

Medicine Business Treatment Data 69

The Cannigma

FEBRUARY 25, 2021

Often simply referred to as caryophyllene, this naturally occurring terpene is not just present in cannabis — it is quite common among plants, including many fruits, vegetables, herbs, and spices. It is a common component of many essential oils and is thought to be present in varying amounts in at least half of all flower-producing plants.

Terpenes 130

Terpenes Oil Cannabinoids Conditions 130

CannaMD

MAY 4, 2021

The scientific model employed in the present study is incredibly trustworthy! and the Netherlands, confirming that the present drug classification systems have little relation to the evidence of harm. Translation? Before beginning their analysis, scientists identified 16 harm criteria. and overseas. Need your medical marijuana card?

Research and Development 105

Research and Development Data Marijuana Treatment 105

Otherside Farms

JANUARY 25, 2019

Lead author Dr. Tim England, honorary consultant stroke physician at the University of Nottingham and Royal Derby Hospital, presented the findings at this week’s annual UK Stroke Forum conference. The data are guiding the next steps in experimental stroke in order to be able to progress onto initial safety assessments in a clinical trial.”.

Clinical Trials 74

Clinical Trials Marijuana Cannabinoids Data 74

Veriheal

JANUARY 26, 2023

A team of researchers, who presented their study results during the Neuroscience 2022 conference , demonstrated that cannabis improves mental performance while reducing risky decision-making, a symptom commonly associated with bipolar disorder. Talk to a medical cannabis doctor to determine a good treatment plan for your symptoms.

Treatment 98

Treatment Cannabinoids Conditions Pharmaceutical 98

Cannabis Chronicles

APRIL 3, 2019

I think the data is too new,” responded Schoening. Later in the session, Washington State Patrol Trooper Ben Taylor told the council that the data is still new and that marijuana legalization hasn’t created a huge increase in traffic fatalities. “I tend to agree with you. Apples to buds to police calls. Sheriff’s Cmdr. Violent crime.

Marijuana 100

Marijuana Data Recreational Business 100

CannaTech

MAY 16, 2019

At this year’s CannaTech Tel Aviv we were completely blown away by the articulate presenters and innovative products being pitched. Kassi is equipped for advanced data collection, offering accurate, real-time, shareable dispensing history, automated reminders and personal recommendations.

Data 13

Data Collective Consumption Treatment 13

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. In other cases, CBDA products — or a mixture of CBD and CBDA — may be preferable, if for instance treatments with high doses of CBD have been unsuccessful for you.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

OCTOBER 15, 2021

At ASHG, Goldfinch Bio will give an oral presentation showcasing insights revealed by its Kidney Genome Atlas (KGA). The presentation details the identification of a novel locus on chromosome 14 which is associated with proteinuric kidney disease and includes data which confirms the well-known association of APOL1 risk haplotypes (i.e.,

Clinical Trials 40

Clinical Trials Research and Development Data Patients 40

Cannabis Law Report

SEPTEMBER 15, 2021

This deceptive marketing of unproven treatments raises significant public health concerns because patients and other consumers may use them instead of approved therapies to treat serious and even fatal diseases. Findings based on NPDS data do not necessarily reflect the opinions of AAPCC. brownies, gummies).

THC 105

THC Pets Events Hemp 105

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.

Research and Development 124

Research and Development Data THC Clinical Trials 124

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. On track to report top-line data by end of 2021. Net loss for the six months ended 30 June 2021 was $30.2 million, or $0.79 million) compared with $24.8 million, or $2.61

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

JUNE 12, 2021

She says the treatment did little but left her feeling numb and unable to heal. “The data was showing that psychedelics were providing benefits to people suffering from anxiety, depression, addiction and PTSD. The treatments were carefully dosed and conducted under medical supervision.

Therapy 81

Therapy Treatment Medicine Sleep 81

Medicinal Genomics

JULY 14, 2022

The truth is that total count tests are not a good indicator of cannabis and hemp product safety for the following reasons: Pathogenic microbes may still be present Testing methods often do not agree Growers are discouraged from using beneficial microbes Growers are encouraged to use remediation. Pathogenic microbes may still be present.

Safety 92

Safety Research and Development Concentrates Food 92

Cannabis Law Report

JULY 20, 2021

With our new psychedelic medicinal insurance solutions, business can access the necessary coverages to protect their business, attract qualified officers/directors, and bring new treatments to market.”. Eric Rahn, Managing Director.

Medicine 75

Medicine Business Research and Development Chronic Pain 75

CannaMD

APRIL 28, 2021

The authors begin by acknowledging the need to clarify the narrative surrounding marijuana use, which over the course of 50 years has moved from institutional demonization to its present and growing status as a socially accepted therapeutic and recreational substance. Find Out if You Qualify. You may be eligible for medical marijuana!

Marijuana 138

Marijuana Data Legalization Consumption 138

Sensi Seeds

DECEMBER 10, 2018

They evaluate data, which is now available thanks to the efforts of the cannabis policy reform movement, and try to provide answers, especially to those who need them most, namely, medical patients. Consequently, they sorted the publications into three main groups: psychiatry, cancer treatment, and neurology.

Medicine 81

Medicine Research and Development Data Policy 81

Cannabis Law Report

SEPTEMBER 1, 2021

While Wednesday’s $2 billion sales milestone does account for initial delivery sales conducted via the three operating licensees, the Commission is not parsing out specific data at this time to maintain driver safety. This past May, the Commission launched the license application for Marijuana Delivery Operators.

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

Canna Law Blog

NOVEMBER 26, 2019

For hemp plant material that was grown elsewhere, the WSDA requires a bill of lading or other documentation demonstrating that the hemp was legally imported into Washington and is legally present in the state. CBD is likely to be present in hemp flower, which can be used in food. Hemp as food. Conclusion .

Hemp 118

Hemp Food Compliance Compliance 118

The Cannigma

OCTOBER 21, 2021

As per usual, more data is needed. Epilepsy is the most obvious example, where the ketogenic diet has been applied for 100 years, cannabis has long been treated as is now also an FDA-approved treatment for a number of seizure disorders. The keto-canna connection: what do keto and cannabis have in common?

Cannabinoids 145

Cannabinoids Edibles Conditions Data 145

Cannabis Law Report

SEPTEMBER 12, 2021

Steve Sisolak signed Assembly Bill 101, making Nevada the first state to legalize the use of cannabinoids as a veterinary treatment. Dr. Dawn Boothe is a professor of veterinary physiology and pharmacology at Auburn University studying cannabis’s potential as a veterinary treatment. Earlier this year, Gov. Cats are more challenging.

Patients 105

Patients Pets Seed-To-Sale Cannabinoids 105

The Joint Blog

DECEMBER 9, 2019

The twice-daily administration of plant-derived CBD-dominant extracts is associated with symptom improvement in adolescents with autism spectrum disorder (ASD), according to observational data published in the journal Frontiers in Neurology. Due to adverse effects, three patients discontinued CE use before 1 month.

CBD 49

CBD Extraction Epilepsy Patients 49

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The popularity of medical cannabinoids (MCs) treatment is growing, as more countries enable MCs treatment for various indications in adults 1. Metrics details.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

JULY 6, 2021

Johnson’s primary area of research expertise is the psychopharmacology of medications for treating addictions, and he is well known in the field for his discovery that topiramate, a gamma-aminobutyric acid (GABA) facilitator and glutamate antagonist, an effective treatment for alcoholism. ” About Ehave, Inc. Ehave, Inc.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97